Pfizer Income from Discontinued Operations 2010-2024 | PFE

Pfizer income from discontinued operations for the twelve months ending June 30, 2024 was $-2M, a 90% decline year-over-year.

  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.
  • Pfizer annual income from discontinued operations for 2021 was $-0.434B, a 117.16% decline from 2020.

Pfizer Income from Discontinued Operations 2010-2024 | PFE

  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.
  • Pfizer annual income from discontinued operations for 2021 was $-0.434B, a 117.16% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B